An interventional study of EPBD and EST in Periampullary Diverticula, sponsored by Renmin Hospital of Wuhan University. Status unknown at 1 site in China. Open to participants aged 16 Years to 75 Years. Per ClinicalTrials.gov, last updated 2020-02-05.
Sponsored by Renmin Hospital of Wuhan University · Not applicable, Interventional, and Treatment
The investigators hypothesized that nipple balloon dilatation could make ERCP more successful and reduce postoperative complications and mortality. So the investigators design this experiment on this assumption.
The incidence of periampullary diverticula in patients with choledocholithiasis is very high at 47.1%. A large number of literatures refered that duodenal papillary diverticulum is a high risk factor for postoperative complications and recurrence of choledocholithiasis . Till now, there have been no randomized controlled trials to explore the effect of nipple balloon dilatation (EPLBD) on the treatment and prognosis of patients with choledocholithiasis complicated with periampullary diverticula (found during ERCP).
104 studies on the registry are indexed under Choledocholithiasis; 23 are open to participants now.
This study's planned enrollment of 128 is above the median of 108 across 70 interventional studies indexed under Choledocholithiasis.
Browse Choledocholithiasis studies →Renmin Hospital of Wuhan University is the lead sponsor of 83 studies on the registry; 27 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Small incision of the duodenal nipple + EPBD
Procedure: EPBD
Large incision of the duodenal nipple
Procedure: EST
Small incision of the duodenal nipple + EPBD
Large incision of the duodenal nipple + EPBD
Incidence of complications
total complications occurded after operation
Time frame: 1 month
time of operation
duration of the ERCP
Time frame: 1-4 hours
postoperative recurrent rate
Recurrence rate of choledocholithiasis
Time frame: 1 year
Plan to share: No
No publications or documents are linked to this record.
This study is status unknown, as verified in Oct 2019. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Renmin Hospital of Wuhan University